|
Atomistry » Calcium » PDB 6tz7-6ul8 » 6ul8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Calcium » PDB 6tz7-6ul8 » 6ul8 » |
Calcium in PDB 6ul8: RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-CarboxamideEnzymatic activity of RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide
All present enzymatic activity of RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide:
2.7.10.2; 2.7.11.1; Protein crystallography data
The structure of RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide, PDB code: 6ul8
was solved by
L.M.Shewchuk,
M.A.Convery,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Calcium Binding Sites:
The binding sites of Calcium atom in the RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide
(pdb code 6ul8). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide, PDB code: 6ul8: Calcium binding site 1 out of 1 in 6ul8Go back to Calcium Binding Sites List in 6ul8
Calcium binding site 1 out
of 1 in the RIP2 Kinase Catalytic Domain Complex with (5S,6S,8R)-2- (Benzo[D]Thiazol-5-Yl)-6-Hydroxy-4,5,6,7,8,9-Hexahydro-5,8- Methanopyrazolo[1,5-A][1,3]Diazocine-3-Carboxamide
Mono view Stereo pair view
Reference:
C.D.Haffner,
A.K.Charnley,
C.J.Aquino,
L.Casillas,
M.A.Convery,
J.A.Cox,
M.A.Elban,
N.C.Goodwin,
P.J.Gough,
P.A.Haile,
T.V.Hughes,
B.Knapp-Reed,
C.Kreatsoulas,
A.S.Lakdawala,
H.Li,
Y.Lian,
D.Lipshutz,
J.F.Mehlmann,
M.Ouellette,
J.Romano,
L.Shewchuk,
A.Shu,
B.J.Votta,
H.Zhou,
J.Bertin,
R.W.Marquis.
Discovery of Pyrazolocarboxamides As Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors. Acs Med.Chem.Lett. V. 10 1518 2019.
Page generated: Tue Jul 16 15:56:31 2024
ISSN: ISSN 1948-5875 PubMed: 31749904 DOI: 10.1021/ACSMEDCHEMLETT.9B00141 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |